Pulmonary aspergilloma is a rare complication of cystic fibrosis and is a contraindication to transplantation. The elimination of an aspergilloma in a 24 year old patient with cystic fibrosis by percutaneous instillation of amphotericin B is described, enabling her to be accepted on a lung transplantation programme. (Thorax 1995;50:809-810) Keywords: cystic fibrosis, aspergilloma, Aspergillus, amphotericin B.
Poor pulmonary function led to referral for lung transplantation but she was thought unsuitable because of likely intraoperative contamination of the pleural space and airways by Aspergillus. We considered whether the aspergilloma might be excised before transplantation but the opinion of the thoracic surgeons was that the dangers of pleural dissemination, infection and respiratory failure would be too great. A one month course of intravenous amphotericin (1 mg/kg/day) failed to show any evidence of a change in the aspergilloma on the CT scan.
Following reports of successful intracavitary treatment of aspergillomas by an indwelling catheter it was decided to attempt this method.'2 A 6-3 French polyethylene pigtail catheter (William Cook Europe, Bjaeverskov, Denmark) was inserted into the cavity using local anaesthesia and CT scan guidance (fig Ib) . An initial dose of 5 mg amphotericin B was injected, gradually increasing to 50 mg/day in 20 ml 5% dextrose. Later a smaller total volume of 5 ml was found to be best. A total of 3 g was given over 60 days. Initially the instillation of this solution caused coughing which was relieved by the instillation of 2-4 ml of 1% lignocaine into the cavity before the amphotericin B. The method was taught to the Case report This patient first came under our care in March 1991 at the age of 20 having been diagnosed as having cystic fibrosis at the age of two years following recurrent pneumonia. In January 1990 she had a right sided pneumothorax treated by intercostal drainage. At the time of referral she weighed 75% of ideal body weight. There was no haemoptysis, but she did have occasional right sided pleuritic chest pain. Her forced expiratory volume in one second (FEV1) was 0-7 1 and forced vital capacity (FVC) was 1 7 1 (21% and 41% ofpredicted). She required pancreatic enzyme supplements and had not been taking inhaled or oral steroids. There was no history of diabetes or tuberculosis. She regularly grew Pseudomonas aeruginosa, Sta- phylococcus aureus, and Aspergellus fumigatus in her sputum. Serum Aspergillus precipitins were positive and her skin prick test to Aspergillus showed no immediate or delayed reaction. Her chest radiograph showed typical features of long standing cystic fibrosis with overinflated lungs and widespread peribronchial thickening.
In addition, a cavity was seen in the right upper lobe. A thoracic computed tomographic (CT) scan showed that the cavity contained an aspergilloma adjacent to the visceral pleura (fig la) . The cavity was entered at fibreoptic bronchoscopy where a grey mass of tissue was seen partially adherent to the wall. A biopsy specimen of the tissue revealed granulation tissue, inflammatory cells, and septate fungi. Treatment with oral itraconazole was started. patient so that most of the course was received at home.
A CT scan of the chest taken at the end of treatment shows an empty cavity (fig lc) . The cavity has remained empty for four months and she continues to take oral itraconazole as her sputum still grows Aspergillus. She 
